Global Therapeutic Drug Monitoring Market by Product (Consumables and Equipment), by Technology (Immunoassays, Chromatography-Spectrometry, and Others), by Drug Class (Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs, Antibiotic Drugs, and Others), by End Users (Hospital, Diagnostic labs, and Research & Academic Institutes), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2027
Global Therapeutic Drug Monitoring Market 
Global Therapeutic Drug Monitoring Market was valued at USD 1.6 billion in 2021 which expected to reach USD 2.9 billion by 2027, at a CAGR 10.42% from 2022-2027.
The goal of therapeutic drug monitoring (TDM), a medical procedure, is to maximise a patient's response to treatment while minimising the risk of negative side effects. By following this procedure, it can be ensured that the patient is receiving the right dosage of their prescription and that there are no unfavourable side effects. It is a useful tool for managing drug treatment and offers several benefits in terms of safety, effectiveness, and individualised care. Using immunoassays, calorimetric immunoassays, and chromatography-mass spectrometry, the concentration of therapeutic drugs is tracked.
Market Driver
Increasing R&D activities and clinical studies to broaden the use of technology in diverse indications, as well as rising rates of cancer, neurological disorders, HIV, autoimmune, and cardiac ailments are anticipated to drive the market growth. For instance, the Journal of Clinical Neurology reported in August 2021 that epilepsy, which affects over 70 million people globally, is the third most prevalent neurological condition after dementia and stroke. More than 55 million people will be living with dementia worldwide in 2021, estimates the WHO. Every year, there would be close to 10 million new cases reported. 
The most prevalent form of dementia, Alzheimer's disease, may be a factor in 60–70% of cases. Thus, it is predicted that over the course of the projection period, rising risks of these diseases will fuel the therapeutic drug monitoring market expansion.
Market Restraint
Healthcare providers hesitation to employ therapeutic drug monitoring services in developing countries is estimated to hamper the market growth during forecast period. High capital investment requirements and the presence of alternatives to the traditional therapeutic drug monitoring market are anticipated to restrain market expansion.
Market Segmentation
Global Therapeutic Drug Monitoring Market is segmented into Product such as Consumables and Equipment. Market is segmented into Technology such as Immunoassays, Chromatography-Spectrometry, and Others. Market is divided into Drug Class such as Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs, Antibiotic Drugs, and Others. Market is segmented into End Users such as Hospital, Diagnostic labs, and Research & Academic Institute.
Regional Analysis
Global Therapeutic Drug Monitoring Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. 
North America estimated to hold major market share during the forecast period due to the presence of numerous players who offer therapeutic drug monitoring products, North America held a significant portion of the global therapeutic drug monitoring market in 2021 and is anticipated to keep this position throughout the forecast period. By monitoring blood or plasma medication concentrations to ensure efficacy and patient compliance, Thermo ScientificTM CEDIATM therapeutic drug monitoring tests, for instance, assist clinicians in calculating the ideal drug dosage for a specific patient.
Key Players
Various key players are listed in the Global Therapeutic Drug Monitoring Market including- Roche AG, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMérieux, Inc., and Alere, Inc. 
Market Taxonomy
By Product 
• Consumables 
• Equipment 
By Technology
• Immunoassays 
• Chromatography-Spectrometry
• Others
By Drug Class 
• Antiepileptic Drugs
• Antiarrhythmic Drugs
• Immunosuppressant Drugs
• Antibiotic Drugs
• Others
By End Users 
• Hospital
• Diagnostic labs
• Research & Academic Institutes
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Global Therapeutic Drug Monitoring Market
1 Introduction 
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Therapeutic Drug Monitoring Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn 
4.2.6 Post covid-19 world Supply & Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Therapeutic Drug Monitoring Market, By Product 
5.1 Y-o-Y Growth Comparison, By Product  
5.2 Global Therapeutic Drug Monitoring Market Share Analysis, By Product  
5.3 Global Therapeutic Drug Monitoring Market Size and Forecast, By Product 
5.3.1. Consumables
5.3.2. Equipment
6 Global Therapeutic Drug Monitoring Market, By Technology
6.1 Y-o-Y Growth Comparison, By Technology
6.2 Global Therapeutic Drug Monitoring Market Share Analysis, By Technology
6.3 Global Therapeutic Drug Monitoring Market Size and Forecast, By Technology
6.3.1. Immunoassays
6.3.2. Chromatography-Spectrometry
63.3. Others
8 Global Therapeutic Drug Monitoring Market, By Drug Class
8.1 Y-o-Y Growth Comparison, By Drug Class
8.2 Global Therapeutic Drug Monitoring Market Share Analysis, By Drug Class
8.3 Global Therapeutic Drug Monitoring Market Size and Forecast, By Drug Class
8.3.1. Antiepileptic Drugs
8.3.2. Antiarrhythmic Drugs
8.3.3. Immunosuppressant Drugs
8.3.4. Antibiotic Drugs
8.3.5 Others
9 Global Therapeutic Drug Monitoring Market, By End User
9.1 Y-o-Y Growth Comparison, By End User
9.2 Global Therapeutic Drug Monitoring Market Share Analysis, By End User
9.3 Global Therapeutic Drug Monitoring Market Size and Forecast, By End User
9.3.1. Hospital
9.3.2. Diagnostic labs
9.3.3. Research & Academic Institutes
10 Global Therapeutic Drug Monitoring Market, By Region
10.1. Global Therapeutic Drug Monitoring Market Share Analysis, By Region
10.2 .Global Therapeutic Drug Monitoring Market Size and Forecast, By Region
11 North America Therapeutic Drug Monitoring Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 North America Therapeutic Drug Monitoring Market Share Analysis, By Product  
11.3 North America Therapeutic Drug Monitoring Market Size and Forecast, By Technology
11.4 Asia Pacific Therapeutic Drug Monitoring Market Size and Forecast, By Drug Class
11.5 North America Therapeutic Drug Monitoring Market Size and Forecast, By End User
11.6 North America Therapeutic Drug Monitoring Market Size and Forecast, By Country
11.6.1 U.S.
11.6.2.Canada
11.6.3. Mexico
12 Europe Therapeutic Drug Monitoring Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Europe Therapeutic Drug Monitoring Market Share Analysis, By Product  
12.3 Europe Therapeutic Drug Monitoring Market Size and Forecast, By Technology
12.4 Asia Pacific Therapeutic Drug Monitoring Market Size and Forecast, By Drug Class
12.5 Europe Therapeutic Drug Monitoring Market Size and Forecast, By End User
12.6 Europe Therapeutic Drug Monitoring Market Size and Forecast, By Country
12.6.1 Germany
12.7.2 France
12.7.3 UK
12.7.4. Rest of Europe
13 Asia Pacific Therapeutic Drug Monitoring Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Asia Pacific Therapeutic Drug Monitoring Market Share Analysis, By Product  
13.3 Asia Pacific Therapeutic Drug Monitoring Market Size and Forecast, By Technology
13.4 Asia Pacific Therapeutic Drug Monitoring Market Size and Forecast, By Drug Class
13.5 Asia Pacific Therapeutic Drug Monitoring Market Size and Forecast, By End User
13.6 Asia Pacific Therapeutic Drug Monitoring Market Size and Forecast, By Country
13.6.1 China 
13.6.2 Japan
13.6.3 India
13.6.4. Rest of Asia Pacific
14 6atin America Therapeutic Drug Monitoring Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Latin America Therapeutic Drug Monitoring Market Share Analysis, By Product  
14.3 Latin America Therapeutic Drug Monitoring Market Size and Forecast, By Technology
14.4 Asia Pacific Therapeutic Drug Monitoring Market Size and Forecast, By Drug Class
14.5 Latin America Therapeutic Drug Monitoring Market Size and Forecast, By End User
14.6 Latin America Therapeutic Drug Monitoring Market Size and Forecast, Country
14.6.1. Brazil
14.6.2. Rest of Latin America
15 Middle East Therapeutic Drug Monitoring Market Analysis and Forecast (2022-2027)
15.1 Introduction
15.2 Middle East Therapeutic Drug Monitoring Market Share Analysis, By Product  
15.3 Middle East Therapeutic Drug Monitoring Market Size and Forecast, By Technology
15.4 Asia Pacific Therapeutic Drug Monitoring Market Size and Forecast, By Drug Class
15.5 Middle East Therapeutic Drug Monitoring Market Size and Forecast, By End User
15.6 Middle East Therapeutic Drug Monitoring Market Size and Forecast, By Country
15.6.1. Saudi Arabia
15.6.2. UAE
15.6.3. Egypt
15.6.4. Kuwait
15.6.5. South Africa
16 Competitive Analysis
16.1 Competition Dashboard
16.2 Market share Analysis of Top Vendors
16.3 Key Development Strategies
17 Company Profiles
17.1 Roche AG
17.1.1 Overview
17.1.2 Offerings
17.1.3 Key Financials
17.1.4 Business Segment & Geographic Overview
17.1.5 Key Market Developments
17.1.6 Key Strategies
17.2 Siemens Healthcare GmbH
17.2.1 Overview
17.2.2 Offerings
17.2.3 Key Financials
17.2.4 Business Segment & Geographic Overview
17.2.5 Key Market Developments
17.2.6 Key Strategies
17.3. Thermo Fisher Scientific, Inc.
17.3.1 Overview
17.3.2 Offerings
17.3.3 Key Financials
17.3.4 Business Segment & Geographic Overview
17.3.5 Key Market Developments
17.3.6 Key Strategies
17.4 Bio-Rad Laboratories, Inc.
17.4.1 Overview
17.4.2 Offerings
17.4.3 Key Financials
17.4.4 Business Segment & Geographic Overview
17.4.5 Key Market Developments
17.4.6 Key Strategies
17.5 Beckman Coulter, Inc.
17.5.1 Overview
17.5.2 Offerings
17.5.3 Key Financials
17.5.4 Business Segment & Geographic Overview
17.5.5 Key Market Developments
17.5.6 Key Strategies
17.6 Abbott Laboratories, Inc.
17.6.1 Overview
17.6.2 Offerings
17.6.3 Key Financials
17.6.4 Business Segment & Geographic Overview
17.6.5 Key Market Developments
17.6.6 Key Strategies
17.7 Agilent Technologies, Inc.
17.7.1 Overview
17.7.2 Offerings
17.7.3 Key Financials
17.7.4 Business Segment & Geographic Overview
17.7.5 Key Market Developments
17.7.6 Key Strategies
17.8 bioMérieux, Inc.
17.8.1 Overview
17.8.2 Offerings
17.8.3 Key Financials
17.8.4 Business Segment & Geographic Overview
17.8.5 Key Market Developments
17.8.6 Key Strategies
17.9 Alere, Inc. 
17.9.1 Overview
17.9.2 Offerings
17.9.3 Key Financials
17.9.4 Business Segment & Geographic Overview
17.9.5 Key Market Developments
17.9.6 Key Strategies